Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Cambrex

More Like This

PR Newswire associated0

Cambrex Advances US and European Expansions

PR Newswire associated0

Cambrex Breaks Ground on $120 Million Expansion in Charles City, Iowa

PR Newswire associated0

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

PR Newswire associated0

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts

PR Newswire associated0

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

PR Newswire associated0

Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility

PR Newswire associated0

Cambrex Announces Sale of Drug Product Business Unit

PR Newswire associated0

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing